Canada markets open in 5 hours 29 minutes

Cosmo Pharmaceuticals N.V. (C43.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
76.000.00 (0.00%)
As of 09:10AM CEST. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
Total Revenue
104,239
102,089
65,074
60,949
Cost of Revenue
20,412
18,762
15,140
10,444
Gross Profit
83,827
83,327
49,934
50,505
Operating Expenses
Selling General and Administrative
3,696
3,550
2,808
4,483
Total Operating Expenses
56,755
55,270
38,833
43,600
Operating Income or Loss
27,072
28,057
11,101
6,905
Interest Expense
9,109
9,159
8,990
8,734
Income Before Tax
19,057
24,473
24,003
-6,931
Income Tax Expense
7,962
6,968
2,330
970
Income from Continuing Operations
11,095
17,505
21,673
-7,901
Net Income
10,840
17,225
21,672
-7,901
Net Income available to common shareholders
10,840
17,225
21,672
-7,901
Basic EPS
0.67
1.05
1.29
-0.55
Diluted EPS
0.67
1.05
1.28
-0.55
Basic Average Shares
16,233
16,425
16,842
14,471
Diluted Average Shares
16,233
16,425
16,904
14,471